Faculty Information |
|
Language | English |
The announcement title | Efficacy and Safety of Sofosbuvir/Velpatasvir plus Ribavirin for 12 or 24 Weeks in Genotype 1 or 2 HCV-Infected Japanese Patients with Prior Treatment Failure to DAA-Based Regimens. |
Academic Society name | The 68th Annual Meeting of the American Association for the Study of Liver Diseases |
Promoters | American Association for the Study of Liver Diseases |
Conference Type | International Society |
Announcement form | Poster presentation |
Lecture Type | Poster sessions |
Publisher and common publisher | Namiki Izumi, Tetsuo Takehara, Kazuaki Chayama, Hiroshi Yatsuhashi, Koichi Takaguchi, Tatsuya Ide, Masayuki Kurosaki, Yoshiyuki Ueno, Hidenori Toyoda, Satoru Kakizaki, Yasuhito Tanaka, Yoshiiku Kawakami, Hirayuki Enomoto, Fusao Ikeda, Deyuan Jiang, Shampa De-Oertel, Brian L. McNabb, Gregory Camus, Luisa Stamm, Diana M. Brainard, John G. McHutchison, Satoshi Mochida, Masashi Mizokami. |
Date | 2017/10/23 |
Venue (city and name of the country) |
Washington DC |
Society abstract | Hepatology 66(suppl1),111A 2017 |